1939 related articles for article (PubMed ID: 11956825)
21. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies.
Harabuchi Y; Imai S; Wakashima J; Hirao M; Kataura A; Osato T; Kon S
Cancer; 1996 May; 77(10):2137-49. PubMed ID: 8640683
[TBL] [Abstract][Full Text] [Related]
22. Extranodal nasal-type natural killer T-cell lymphoma in an adolescent from Bangladesh.
Pol-Rodriguez MM; Fox LP; Sulis ML; Miller IJ; Garzon MC
J Am Acad Dermatol; 2006 May; 54(5 Suppl):S192-7. PubMed ID: 16631938
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases.
Schwartz EJ; Molina-Kirsch H; Zhao S; Marinelli RJ; Warnke RA; Natkunam Y
Am J Clin Pathol; 2008 Sep; 130(3):343-51. PubMed ID: 18701406
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.
Gualco G; Domeny-Duarte P; Chioato L; Barber G; Natkunam Y; Bacchi CE
Am J Surg Pathol; 2011 Aug; 35(8):1195-203. PubMed ID: 21716086
[TBL] [Abstract][Full Text] [Related]
25. [Study of the pathology, immunophenotype, etiology and genetic marker of NK/T-cell lymphoma].
Zhong BN; Zhang XH; Li M; Cao HG; Li N; Liu CY; Gu YQ; Gao ZF
Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):505-9. PubMed ID: 14690577
[TBL] [Abstract][Full Text] [Related]
26. Nasal and nasal-type natural killer (NK)/T-cell lymphoma: immunophenotype and Epstein-Barr virus (EBV) association.
Peh SC; Quen QW
Med J Malaysia; 2003 Jun; 58(2):196-204. PubMed ID: 14569739
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
[TBL] [Abstract][Full Text] [Related]
28. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.
Zhang S; Li T; Zhang B; Nong L; Aozasa K
Hum Pathol; 2011 Sep; 42(9):1319-28. PubMed ID: 21329961
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas.
Brink AA; ten Berge RL; van den Brule AJ; Willemze R; Chott A; Meijer CJ
J Pathol; 2000 Aug; 191(4):400-6. PubMed ID: 10918215
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.
Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M
Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388
[TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.
Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH
Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900
[TBL] [Abstract][Full Text] [Related]
34. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
[TBL] [Abstract][Full Text] [Related]
35. [NK-cell lymphomas and NK-like T-cell lymphomas].
Oshimi K
Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two cases.
Kagami Y; Sobue R; Ito N; Yatabe Y; Taji H; Suzuki R; Seto M; Ogura M; Suchi T; Morishima Y; Nakamura S
Int J Hematol; 1999 Aug; 70(2):105-11. PubMed ID: 10497849
[TBL] [Abstract][Full Text] [Related]
37. Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms.
Chuang SS; Lin CN; Li CY
Cancer; 2000 Oct; 89(7):1586-92. PubMed ID: 11013375
[TBL] [Abstract][Full Text] [Related]
38. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
39. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
40. Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity.
Mukai HY; Hasegawa Y; Kojima H; Okoshi Y; Takei N; Yamashita Y; Nagasawa T; Mori N
Mod Pathol; 2002 Nov; 15(11):1131-9. PubMed ID: 12429791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
